Table 1.
Test/Subgroup | N | Age | Gender | Education | Chronicity | |
---|---|---|---|---|---|---|
FRT | Impaired | 38 | 54.2 (13.2) | 11W; 27M | 12.8 (2.4) | 3.2 (4.7) |
Unimpaired | 163 | 50.8 (15.5) | 72W; 91M | 12.9 (2.4) | 2.4 (3.3) | |
JLO | Impaired | 23 | 51.7 (13.7) | 13W; 10M | 12.4 (2.1) | 2.3 (3.6) |
Unimpaired | 158 | 51.1 (15.9) | 62W; 96M | 13.1 (2.5) | 3.0 (3.9) |
N = number of participants; W = women; M = men. The data for Age, Education, and Chronicity are given as means (SDs in parentheses), in years. Chronicity refers to the time since lesion onset that the patients received the FRT and JLO tests. Subgroup differences in Age, Education, and Chronicity for the two tests (FRT, JLO) were not significant per t-tests (all p’s > .20).